Paper42579199
Astrocyte-Microglia Crosstalk in Post-Hemorrhagic Neurovascular Microenvironment: Mechanistic Nodes, Cross-Stroke Comparisons, and Therapeutic Reprogramming.
Ye F and 4 others. Transl Stroke Res, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Astrocyte-Microglia Crosstalk in Post-Hemorrhagic Neurovascular Microenvironment: Mechanistic Nodes, Cross-Stroke Comparisons, and Therapeutic Reprogramming. Papers, record 42579199. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42579199
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Astrocyte-Microglia Crosstalk in Post-Hemorrhagic Neurovascular Microenvironment: Mechanistic Nodes, Cross-Stroke Comparisons, and Therapeutic Reprogramming.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Astrocytes | Major topic |
| Microglia | Major topic |
| Cerebral Hemorrhage | Major topic |
| Stroke | Major topic |
| Humans | |
| Animals | |
| Blood-Brain Barrier |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2025HXBH142 | West China Hospital, Sichuan University | PubMed | ||
| 2025RCM013 | Luzhou Science and Technology Bureau | PubMed | ||
| 2025YFA1804600 | National Key Research and Development Program of China | PubMed | ||
| 82173175 | National Natural Science Foundation of China | PubMed |
Source PubMed
References220
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35420918 | Cerebral Hemorrhage: Pathophysiology, Treatment, and Future Directions. | Circ Res | 2022 | https://conductscience.org/library/papers/35420918 | PubMed |
| 2 | 34671423 | Secondary mechanisms of injury and viable pathophysiological targets in intracerebral hemorrhage. | Ther Adv Neurol Disord | 2021 | https://conductscience.org/library/papers/34671423 | PubMed |
| 3 | 37713268 | Anakinra in cerebral haemorrhage to target secondary injury resulting from neuroinflammation (ACTION): Study protocol of a phase II randomised clinical trial. | Eur Stroke J | 2024 | https://conductscience.org/library/papers/37713268 | PubMed |
| 4 | 27658510 | Purinergic Signalling and Neurological Diseases: An Update. | CNS Neurol Disord Drug Targets | 2017 | https://conductscience.org/library/papers/27658510 | PubMed |
| 5 | 7490620 | Current concepts of brain edema. Review of laboratory investigations. | J Neurosurg | 1995 | https://conductscience.org/library/papers/7490620 | PubMed |
| 6 | 30898550 | Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial. | Lancet Neurol | 2019 | https://conductscience.org/library/papers/30898550 | PubMed |
| 7 | 33629275 | Neurovascular Units and Neural-Glia Networks in Intracerebral Hemorrhage: from Mechanisms to Translation. | Transl Stroke Res | 2021 | https://conductscience.org/library/papers/33629275 | PubMed |
| 8 | 36361561 | Platelets and Their Role in Hemostasis and Thrombosis-From Physiology to Pathophysiology and Therapeutic Implications. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36361561 | PubMed |
| 9 | 23055972 | Impairment of interrelated iron- and copper homeostatic mechanisms in brain contributes to the pathogenesis of neurodegenerative disorders. | Front Pharmacol | 2012 | https://conductscience.org/library/papers/23055972 | PubMed |
| 10 | 32466767 | TREM2 activation attenuates neuroinflammation and neuronal apoptosis via PI3K/Akt pathway after intracerebral hemorrhage in mice. | J Neuroinflammation | 2020 | https://conductscience.org/library/papers/32466767 | PubMed |
| 11 | 30898863 | Neutrophil transendothelial migration: updates and new perspectives. | Blood | 2019 | https://conductscience.org/library/papers/30898863 | PubMed |
| 12 | 39676669 | Pathophysiology of Intracerebral Hemorrhage: Recovery Trajectories. | Stroke | 2025 | https://conductscience.org/library/papers/39676669 | PubMed |
| 13 | 34789008 | Effect of Deferoxamine on Outcome According to Baseline Hematoma Volume: A Post Hoc Analysis of the i-DEF Trial. | Stroke | 2022 | https://conductscience.org/library/papers/34789008 | PubMed |
| 14 | 38622710 | Analysis of ischemic stroke-mediated effects on blood-brain barrier properties along the arteriovenous axis assessed by intravital two-photon imaging. | Fluids Barriers CNS | 2024 | https://conductscience.org/library/papers/38622710 | PubMed |
| 15 | 36430330 | The Role of Copper Homeostasis in Brain Disease. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36430330 | PubMed |
| 16 | 34439518 | Targeting Pro-Oxidant Iron with Deferoxamine as a Treatment for Ischemic Stroke: Safety and Optimal Dose Selection in a Randomized Clinical Trial. | Antioxidants (Basel) | 2021 | https://conductscience.org/library/papers/34439518 | PubMed |
| 17 | 37179244 | Perihematomal edema-based CT-radiomics model to predict functional outcome in patients with intracerebral hemorrhage. | Diagn Interv Imaging | 2023 | https://conductscience.org/library/papers/37179244 | PubMed |
| 18 | 39765770 | The Neural Palette of Heme: Altered Heme Homeostasis Underlies Defective Neurotransmission, Increased Oxidative Stress, and Disease Pathogenesis. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39765770 | PubMed |
| 19 | 34113618 | The Role of Astrocytes in the Neurorepair Process. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34113618 | PubMed |
| 20 | 41628627 | Efficacy and safety of minocycline in patients with acute ischaemic stroke (EMPHASIS): a multicentre, double-blind, randomised controlled trial. | Lancet | 2026 | https://conductscience.org/library/papers/41628627 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CGAS | 115004 | PubTator's text mining | https://conductscience.org/library/genes/115004 | NCBI Gene |
| F2 | 2147 | PubTator's text mining | https://conductscience.org/library/genes/2147 | NCBI Gene |
| FGB | 2244 | PubTator's text mining | https://conductscience.org/library/genes/2244 | NCBI Gene |
| IFNA1 | 3439 | PubTator's text mining | https://conductscience.org/library/genes/3439 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42579199
GET https://conductscience.org/api/papers/v1/42579199/references?page=2